Mitogenic and Apoptotic Actions of Epidermal Growth Factor on Neuroblastoma Cells Are Concentration-Dependent

Journal of Surgical Research

Volumn 135, Issue 2, 2006, Pages 209-212

  Chiu, Bill ^a   Mirkin, Bernard ^a   Madonna, Mary Beth ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

epidermal growth factor; neuroblastoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIBODY; CASPASE 3; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; RAF PROTEIN;

ADOPTIVE IMMUNOTHERAPY; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL LYSATE; CELL PROLIFERATION; CHEMICAL ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA PROBE; HUMAN; HUMAN CELL; MITOGENESIS; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; HUMANS; SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS; THIAZOLES;

EID: 33748761930     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.04.018     Document Type: Article

References (23)

1. Armstrong D.K., Kaufmann S.H., Ottaviano Y.L., et al. Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res 54 (1994) 5280
2. Gulli L.F., Palmer K.C., Chen Y.Q., et al. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity. Cell Growth Differ 7 (1996) 173
3. Olayioye M.A., Neve R.M., Lane H.A., et al. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19 (2000) 3159
4. Person D.L., Yazlovitskaya E.M., Cui W., et al. Cisplatin-induced activation of mitogen-activated protein kinase in ovarian carcinoma cells: inhibition of extracellular signal-regulated activity increases sensitivity to cisplain. Clin Cancer Res 5 (1999) 1007
5. Gille H., and Downward J. Multiple ras effector pathways contribute to G(1) cell cycle progression. J Biol Chem 274 (1999) 22033
6. Jiang B.H., Zheng J.Z., Aoki M., et al. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA 97 (2000) 1749
7. Franke T.F., Yang S.I., Chan T.O., et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81 (1995) 727
8. Qiu Q., Yang M., Tsang B.K., et al. Both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling are required in epidermal growth factor-induced human trophoblast migration. Mol Hum Reprod 10 (2004) 677
9. Datta S.R., Dudek H., Tao X., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231
10. Zha J., Harada H., Yang E., et al. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87 (1996) 619
11. Bonni A., Brunet A., West A.E., et al. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286 (1999) 1358
12. Harper S.J., and LoGrasso P. Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal 13 (2001) 299
13. Ballif B.A., and Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 12 (2001) 397
14. Welsh G.I., and Proud C.G. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J 294 (1993) 625
15. Welsh G.I., Miller C.M., Loughlin A.J., et al. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett 421 (1998) 125
16. Saito Y., Vandenheede J.R., and Cohen P. The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells. Biochem J 303 (1994) 27
17. Pap M., and Cooper G.M. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem 273 (1998) 19929
18. Sutherland C., and Cohen P. The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Lett 338 (1994) 37
19. van Weeren P.C., de Bruyn K.M., de Vries-Smits A.M., et al. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. J Biol Chem 273 (1998) 13150
20. Wells A. EGF receptor. Int J Biochem Cell Biol 31 (1999) 637
21. Janet T., Ludecke G., Otten U., et al. Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: correlation with expression of growth factors and growth factor receptors. J Neurosci Res 40 (1995) 707
22. Layfield L.J., Thompson J.K., Dodge R.K., et al. Prognostic indicators for neuroblastoma: stage, grade, DNA ploidy, MIB-1-proliferation index, p53, HER-2/neu and EGFr-a survival study. J Surg Oncol 59 (1995) 21
23. Ho R., Minturn J.E., Hishiki T., et al. Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res 65 (2005) 9868